Modern Australian

Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine

ROCHESTER, MINN., US / SINGAPORE – Media OutReach Newswire – 23 September 2026 – Mayo Clinic Laboratories and Pathology Asia Holdings (PAH) have announced a strategic investment and collaboration aimed at expanding access to advanced diagnostics and precision medicine across Southeast Asia, Australia and New Zealand.



Mayo Clinic Laboratories and PAH are deepening a long-term relationship that brings together Mayo's global clinical and diagnostic expertise with the regional healthcare network, capabilities and market knowledge of PAH and its genomics subsidiary, LifeStrands Genomics. William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, has been appointed Scientific Adviser to PAH.

Genomics is a central focus of the collaboration, delivered through LifeStrands Genomics. Mayo Clinic Laboratories and LifeStrands Genomics will work together to broaden access to advanced molecular and genomic testing across Southeast Asia, Australia and New Zealand, with applications spanning the identification of genetic conditions, disease risk assessment, diagnosis, and treatment planning, enabling healthcare providers to integrate clinically relevant genomic insights into more personalised patient care.

LifeStrands Genomics will operate as "LifeStrands in collaboration with Mayo Clinic Laboratories" in certain markets, reflecting the organisations' shared commitment to expanding access to advanced genomic testing and precision medicine across the region.

Together, the organisations will pursue joint scientific initiatives, education and thought leadership to support the integration of genomics into patient care. "Healthcare providers across Southeast Asia, Australia and New Zealand are increasingly seeking advanced diagnostic solutions to guide patient care," said Dr. Morice. "Our collaboration with PAH and LifeStrands Genomics reflects our commitment to a long-term strategic relationship that unites complementary strengths in laboratory diagnostics and genomics. Through this collaboration, we are bringing advanced diagnostic capabilities closer to patients and equipping healthcare providers with the insights needed to deliver personalised care."

"Mayo Clinic Laboratories' investment marks an important milestone in our relationship and a strong foundation for the next phase of diagnostic innovation across the region," Christopher Ting, M.D., founder and CEO of Pathology Asia Holdings, added. "Combining Mayo Clinic Laboratories' global clinical and scientific expertise with PAH's regional diagnostic capabilities and network will enable us to broaden access to advanced testing and increase access to genomics and precision medicine capabilities across Southeast Asia, Australia and New Zealand."

Hashtag: #MayoClinicLaboratories #PathologyAsia #LifeStrands #LifeStrandsGenomics #LifeStrandsGenomicsAustralia #DNALAB #DNALaboratories #PrecisionMedicine



The issuer is solely responsible for the content of this announcement.

Mayo Clinic Laboratories

Mayo Clinic Laboratories, the global leader in turning test results into clinical answers, provides advanced testing and pathology services for healthcare organisations worldwide in partnership with Mayo Clinic's Department of Laboratory Medicine and Pathology. Mayo Clinic Laboratories offers more than 4,400 tests and pathology services, delivering specialised diagnostic expertise to help healthcare providers make informed decisions and improve patient care.

Pathology Asia

Pathology Asia is a leading regional provider of pathology and laboratory diagnostics services, with operations across Singapore, Malaysia, Indonesia, Thailand, Vietnam, the Philippines and Australia. Its network encompasses established diagnostics brands including Innoquest, Singapore Diagnostics, TissuPath and Safework Health, as well as its specialist genomics businesses, LifeStrands Genomics and DNA Laboratories. Pathology Asia delivers a comprehensive range of pathology, molecular and genomic testing services to healthcare providers, hospitals and patients across the region through its network of internationally accredited laboratories.


LifeStrands Genomics

LifeStrands Genomics is a leading Asia-Pacific clinical genomics company comprising three specialist laboratories: LifeStrands Genomics Singapore, LifeStrands Genomics Australia, and DNA Laboratories. Together, the group provides advanced molecular and genomic testing across oncology, reproductive health, inherited disorders and wellness. Operating through CAP- and ISO 15189-accredited laboratories, LifeStrands Genomics delivers clinically actionable insights that empower healthcare professionals to make informed decisions, advance personalised care and improve patient outcomes.

Your Baby's First Year: A Local Guide to Feeding, Sleep, and When to Get Extra Support

Ask ten parents in a Brisbane mothers' group how their baby is feeding or sleeping, and expect ten different answers.  Someone's baby sleeps throug...

Kitchen and Laundry Makeover Ideas That Don't Require a Full Renovation

Full kitchen renos are expensive — and most people don't actually need one.  They need the kitchen to stop looking like it's stuck in 2009, or they...

How Technology Is Reshaping the Modern Australian Commercial Kitchen

The commercial kitchen has always been shaped by technology. Refrigeration changed how ingredients could be stored, modern ventilation transformed k...

The Number on a Roller Blind Fabric That Nobody Explains

Somewhere in the fabric book, next to the colour name, there is a percentage. Three per cent. Five per cent. Ten per cent. Nobody explains it, most c...

What’s Trending in Men’s Jewellery This Father’s Day!

Finding a Father’s Day gift that feels personal, stylish and genuinely wearable is not always easy. While socks and novelty mugs have traditionally ...

Road Signs: Understanding Their Role in Clear and Effective Signage

Effective signage and display hardware can help businesses communicate information, promote products and organise customer or visitor movement. Road...

Bottle Label Printing: Key Factors to Consider Before Your Next Packaging Run

Effective packaging begins with understanding the product, bottle material, artwork and production requirements when planning bottle label printing. H...

Planning a Long-Distance Move With Interstate Movers Melbourne

Moving between states involves more planning than a typical local relocation. Along with packing and transporting household belongings, you need to...

Understanding the Role of an I/O Controller in Industrial Automation

Modern industrial systems depend on accurate communication between sensors, machines and control systems. An I/O controller can help manage this commu...

How the Right Mining Hose Supports Demanding Operations

Mining environments place considerable demands on equipment used for material transfer, water management and processing. Hoses operating in these co...

Simple Ideas for Making Social Gatherings More Memorable

We have all been to those parties where everyone just stands around the kitchen island, staring at their phones, waiting for someone else to make a mo...

Outdoor Wall Lights: Improving Exterior Lighting Around Your Home

Lighting can influence how a room looks, feels and functions, so the right fitting should be selected according to both appearance and practical req...

Commercial Office Cleaning: Combining Routine Office Cleaning With Melbourne Service

Keeping a workplace clean requires a service that can accommodate everyday tasks as well as the particular needs of the business. Professional comme...

Caravan Sales in Queensland: How to Find the Right Caravan for Sale QLD

Caravan ownership is about more than having somewhere to sleep while travelling. For many Queenslanders, it is one of the best ways to explore regio...

What Sir Walter Buffalo Turf Actually Costs in 2026 (And Why Quotes Vary So Much)

Two quotes landed on a Hills District homeowner's kitchen table last spring for the exact same 80-square-metre backyard. One said $12 a metre. The o...

Nearly 1,300 NSW Hospital Beds Are Occupied By People Who Are Ready To Go Home

1,276 people in NSW hospitals have been medically cleared for discharge but remain in hospital because they're still waiting for NDIS or aged care sup...

National Survey Launched to Measure Operational Impacts of Federal NDIS Policy Reforms

The effects of recent NDIS reforms are beginning to move beyond policy papers and into day to day service delivery. A new national survey is asking ...

Beyond the Nappy Cake: Baby Shower Gifts That Get Used

What new Australian parents unwrap, keep, and quietly thank you for months later. Six weeks after my daughter was born, I did an audit of the baby sh...